Correspondingly, through the METTL3/miR-181d-5p axis, METTL3 decreases the susceptibility of CRC cells to 5-fururacil (5-FU) and enhances exosome miR-181b-5p in CAFs (Pan et al., 2022). This evidence concerns the gene METTL3 and colorectal carcinoma.